泽泻提取物对糖脂代谢的影响及潜在机制:啮齿动物研究的系统综述与Meta分析
该系统综述与Meta分析纳入29项啮齿动物研究,评估泽泻提取物对糖脂代谢紊乱的疗效及潜在机制。结果显示泽泻提取物可改善空腹血糖、餐后2小时血糖、糖耐量与胰岛素耐量试验曲线下面积、HOMA-IR、甘油三酯、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、体重及肝脏TG和TC水平。潜在机制包括抗氧化、抗炎、调节脂代谢、抑制糖异生、增强胰岛素信号、促进自噬及抗纤维化。
要点
- 泽泻提取物在啮齿动物中可改善空腹血糖、餐后血糖及胰岛素抵抗指标。
- 泽泻提取物可降低甘油三酯、总胆固醇、LDL-C并升高HDL-C。
- 潜在机制涉及抗氧化、抗炎、调节脂代谢、抑制糖异生及增强胰岛素信号等。
核心结论
- 泽泻提取物在啮齿动物模型中可改善糖脂代谢紊乱,但现有研究有限,需设计良好的研究验证。
研究设计与样本
- 系统检索生物医学及中文数据库,纳入29项啮齿动物临床前研究。
- 采用SYRCLE偏倚风险工具评估研究质量,统计分析遵循CHSRI标准并使用Stata 17.0软件。
主要发现
- 泽泻提取物可改善空腹血糖、餐后2小时血糖、糖耐量试验及胰岛素耐量试验曲线下面积、HOMA-IR。
- 泽泻提取物可改善甘油三酯、总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、体重及肝脏TG和TC水平。
- 潜在机制包括抗氧化、抗炎、调节脂代谢、抑制糖异生、增强胰岛素信号、促进自噬及抗纤维化。
临床怎么用
- 在中医及中西医结合诊疗中,可将泽泻提取物作为糖脂代谢紊乱的潜在辅助治疗选项参考。
- 应用时需结合患者具体情况,并告知现有证据主要来自啮齿动物研究,临床疗效尚待验证。
局限性
- 现有研究数量有限,纳入研究均为啮齿动物实验,结果外推至人体需谨慎。
- 研究间异质性及偏倚风险可能影响结论可靠性,需设计良好的研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Alismatis Rhizoma (AR), derived from the dried rhizomes of Alisma orientale (Sam.) Juz. or Alisma plantago-aquatica L., is widely used in traditional Chinese medicine to treat hyperlipidemia, diabetes, infections, edema, and inflammation. Emerging evidence shows AR extracts regulate glucose and lipid metabolism in rodents. AIM OF THE STUDY: This study intends to evaluate the efficacy and potential mechanisms of AR extracts in treating glucose and lipid metabolism disorders in rodent models. MATERIALS AND METHODS: A systematic search of biomedical and Chinese databases identified relevant preclinical studies. Study quality was assessed by SYRCLE's risk-of-bias tool. Statistical synthesis adhered to CHSRI standards, with analytical procedures implemented using Stata 17.0 statistical software. RESULTS: The final selection comprised 29 eligible preclinical studies. The findings suggest that AR extracts can improve glucose and lipid metabolism-related indicators, including fasting plasma glucose (FPG), 2-h postprandial glucose (2hPG), area under the curve (AUC) for glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs), homeostatic model assessment of insulin resistance (HOMA-IR), triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), body weight, and liver levels of TG and TC. The potential mechanisms of these effects include antioxidant effects, anti-inflammatory effects, regulation of lipid metabolism, inhibition of gluconeogenesis, enhancement of insulin signaling, promotion of autophagy, and anti-fibrotic effects. CONCLUSION: AR extracts exhibit therapeutic promise in rectifying glucose and lipid dysregulation in rodent models. However, current research is limited, and well-designed studies are needed to validate these findings.
引用
- Zhu D, Zhang B, Tan H, et al. Effects and potential mechanisms of Alismatis Rhizoma extracts on glucose and lipid metabolism: A systematic review and meta-analysis of rodent studies. J Ethnopharmacol. 2025. PMID: 40825387. doi:10.1016/j.jep.2025.120386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。